Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI-Reference-Cited by-同舟云学术

Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI

Published:2012-01-06 Issue:4 Volume:18 Page:1146-1155
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Wieduwilt Matthew J.,Valles Francisco,Issa Samar,Behler Caroline M.,Hwang James,McDermott Michael,Treseler Patrick,O'Brien Joan,Shuman Marc A.,Cha Soonmee,Damon Lloyd E.,Rubenstein James L.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study;Signal Transduction and Targeted Therapy;2024-09-04

2. Preoperative prediction of pathologic response to neoadjuvant immunotherapy in resectable locally advanced head and neck squamous cell carcinoma using multiparametric MRI;Chinese Journal of Academic Radiology;2024-08-08

3. Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101;Blood Advances;2024-06-14

4. Letter to editor: C‑reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase‑to‑lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single‑center study of 223 patients;Neurosurgical Review;2024-04-11

5. Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma;The Oncologist;2024-04-06